LARA GAVALDON: Open Payments
NPI 1962042796 · BENZONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 33 payments from 10 companies in 2025. Trend: 2023 $1,109 · 2024 $1,503 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $206 |
| ABBVIE INC. | 17 | $200 |
| Braeburn Inc. | 1 | $120 |
| Aimmune Therapeutics, Inc. | 1 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Novo Nordisk Inc | 2 | $36 |
| Astellas Pharma US Inc | 2 | $29 |
| Exact Sciences Corporation | 1 | $19 |
| Indivior Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: BREZTRI, BRIXADI, AIRSUPRA, UBRELVY, QULIPTA, ZENPEP, VRAYLAR, REXULTI.
Industry payments across MI — which companies pay providers there.
